Late toxicities of cancer drugsCardiac, pulmonary, sexual, and neurologic toxicities that develop or persist after completing cancer drug therapy New U.S. guideline nixes prostate cancer screening in under-55sTwo-year interval suggested for older men who opt for testing Robot fails to impress in bladder cancer surgery High-tech approach no better than conventional open procedure Prostate cancer: More men can opt for active surveillance Not all conventional criteria need to be fulfilled, analysis shows Implants a cancer hazard New Drug: Perjeta for the treatment of HER2-positive metastatic breast cancer New drug is a recombinant, humanized, monoclonal antibody. Intermittent versus continuous prostate cancer therapy: New trial raises cautions in metastatic disease Researchers unable to conclude the two strategies produce equivalent results Made-in-Canada technology aims to zap early prostate cancer Safety trial of MRI-guided ultrasound ablation launched in Ontario MRI an option for colon screening? Technique has the advantage of avoiding radiation exposure New retinoblastoma discovered First Previous 44 45 46 47 48 Next Last
